Indigenous drugs in ischemic heart disease in patients with diabetes

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 11, 2009, Pages 1215-1221

  Dwivedi, Shridhar ^a   Aggarwal, Amitesh ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AEGELINE 2; ALKALOID; ALLICIN; ALLYL CYSTEINE SULPHOXIDE; APIGENIN; CHARANTIN; CRATEGELICA ACID; CURCUMIN; FLAVONOID; GARLIC OIL; GYMNEMICA ACID; KAEMPFEROL; KOENIGICINE; KOENIMBINE; LEUCODELPHINDIN; LUPEOL; LUTEOLIN; METHYL CYSTEINE SULPHOXIDE; MYRICETIN; NIMBIDIN; OLEANOLIC ACID; ORIENTIN; PELORGONIDIN; PHYTOSTEROLIN; PYCNOGENOL; QUERCETIN; QUERCITOL; SCOLOPETIN; TRITERPENIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AEGLE; ANTICOAGULATION; AZADIRACHTA INDICA; CLINICAL TRIAL; CURCUMA LONGA; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; EUGENIA; FICUS; GARLIC; GLYCYRRHIZA; GYMNEMA SYLVESTRE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; ISCHEMIC HEART DISEASE; LONG TERM CARE; MEDICINAL PLANT; MOLECULE; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANGIOSPERMS; ANTILIPEMIC AGENTS; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FLAVONOIDS; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; IMMUNOLOGIC FACTORS; MYOCARDIAL ISCHEMIA; PLANT EXTRACTS;

EID: 70450202238     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2009.0187     Document Type: Review

References (86)

1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365:217-223.
2. Gupta R. Burden of coronary heart disease in India. Indian Heart J 2005;57:632-638.
3. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case control study. Lancet 2004;364:937-952.
4. King H, Auburt RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates and projections. Diabetes Care 1998;21:1414-1431.
5. Barnett AH, Dixon AN, Bellary S, et al. Type 2 diabetes and cardiovascular risk in the UK South Asian community. Diabetologia 2006;49:2234-2246.
6. Dwivedi G, Dwivedi S. Sushruta-the clinician-teacher par excellence. Ind J Chest Allied Sci 2007;48:51-52.
7. Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 2002;23:831-834.
8. Haffner SM. Prediabetes, insulin resistance, inflammation and cardiovascular disease risk. Diabetes Res Clin Pract 2003;61:S9-S18.
9. Dwivedi S. Putative use of Indian cardiovascular friendly plants in preventive cardiology. Ann Natl Acad Med Sci 1996;32:159-175.
10. Sharma SB, Dwivedi S. Medicinal plants with hypolipidemic activities. Indian Drugs 1997;34:242-251.
11. Channon KM. The endothelium and the pathogenesis of atherosclerosis. Med Int 2006;34:173-177.
12. Kesari AN, Gupta RK, Singh SK, et al. Hypoglycemic and antihyperglycemic activity of Aegle marmelos seed extract in normal and diabetic rats. J Ethnopharma 2006;107:374-379.
13. Upadhya S, Shanbhag KK, Suneetha G, et al. A study of hypoglycemic and antioxidant activity of Aegle marmelos in alloxan induced diabetic rats. Indian J Physiol Pharmacol 2004;48:476-480.
14. Narender T, Shweta S, Tiwari P, et al. Antihyperglycemic and antidyslipidemic agent from Aegle marmelos. Bioorg Med Chem Lett 2007;17:1808-1811.
15. German Commission E Monograph, Allii cepae bulbus. Bundesanzeiger 1986;50:13.
16. Srivastava KC. Effects of aqueous extracts of onion, garlic and ginger on platelet aggregation and metabolism of arachidonic acid in the blood vascular system: An in vitro study. Prostagland Leukotrienes Med 1984;13:227-235.
17. Srivastava KC. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism. Biomed Biochem Acta 1984;43:S335-S346.
18. Chauhan LS, et al. Effect of onion, garlic and clofibrate on coagulation and fibrinolytic activity of blood in cholesterol fed rabbits. Indian Med J 1982;76:126-127.
19. Makheja AN, Vanderhoek JY, Bailey JM. Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic. Lancet 1979;1:781.
20. Ariga T, Oshiba S. Effects of the essential oil components of garlic cloves on rabbit platelet aggregation. Igaku To Seibutsugaku 1981;102:169-174.
21. Vanderhoek JY, Makheja AN, Bailey JM. Inhibition of fatty acid oxygenases by onion and garlic oils: Evidence for the mechanism by which these oils inhibit platelet aggregation. Biochem Pharmacol 1980;29:3169-3173.
22. Weissenberger H, et al. Isolation and identification of the platelet aggregation inhibitor present in onion: Allium cepa. FEBS Lett 1972;26:105-108.
23. Doutremepuich C, et al. Effects of onion, Allium cepa L., on primary haemostasis in healthy voluntary person before and after high fat meal absorption. Ann Pharmaceut Françaises 1985;43:273-280.
24. Breu W, Dorsch W. Allium cepa L. (Onion): Chemistry, analysis and pharmacology. In: Wagner H, Farnsworth NR, eds. Economic and Medicinal Plants Research, Vol.6. London: Academic Press, 1994:115-147.
25. Jain RC, Vyas CR. Hypoglycaemic actions of onion on rabbits. Br Med J 1974;2:730.
26. Singhvi S, et al. Effect of onion and garlic on blood lipids. Rajasthan Med J 1984;23:3-6.
27. Sharma KK, Sharma SP. Effect of onion and garlic on serum cholesterol on normal subjects. Mediscope 1979;22:134-136.
28. Sharma KK, Sharma SP. Effect of onion on blood cholesterol, fibrinogen and fibrinolytic activity in normal subjects. Indian J Pharmacol 1976;8:231-233.
29. Jain RC, Vyas CR, Mahatma OP. Hypoglycaemic action of onion and garlic. Lancet 1973;2:1491.
30. Sharma KK et al. Antihyperglycemic effect of onion: Effect on fasting blood sugar and induced hyperglycemia in man. Indian J Med Res 1977;65:422-429.
31. Adler AJ, Holub BJ. Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr 1997;65:445-450.
32. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia: A meta-analysis of randomised clinical trials. Ann Intern Med 2000;133:420-429.
33. Petkov V. Pharmacological and clinical studies of garlic. Deutsche Apotheker Zeitung 1966;106:1861-1867.
34. Ogawa H, et al. Effect of garlic powder on lipid metabolism in stroke-prone spontaneously hypertensive rats. Nippon Eiyo Shokuryo Gakkaishi 1993;46:417-423.
35. Sanfilippo G, Ottaviano G. Pharmacological investigations on Allium sativum. I. General action: Action on the arterial pressure and on the respiration. Boll Soc Ital Biol Sperimentale 1944;19:156-158.
36. Foushee DB, Ruffin J, Banerjee U. Garlic as a natural agent for the treatment of hypertension: A preliminary report. Cytobios 1982;35:145-152.
37. Ozturk Y, et al. Endothelium-dependent and independent effects of garlic on rat aorta. J Ethnopharmacol 1994;44:109-116.
38. Koch HP, Lawson LD, eds. Garlic, the Science and Therapeutic Application of Allium sativum l and Related Species. Baltimore: Williams and Wilkins, 1996.
39. Bordia A, et al. Effect of essential oil of onion and garlic on experimental atherosclerosis in rabbits. Atherosclerosis 1977; 26:379-386. (Pubitemid 8038232)
40. Bordia A, Verma SK. Effect of garlic on regression of experimental atherosclerosis in rabbits. Artery 1980;7:428-437.
41. Materia Medika Indonesia, Jilid VI. Jakarta: Departemen Kesehatan, Republik Indonesia, 1995.
42. Lawson LD, Hughes BG. Inhibition of whole blood plateletaggregation by compounds in garlic clove extracts and commercial garlic products. Thrombosis Res 1992;65:141-156.
43. Agarwal KC. Therapeutic actions of garlic constituents. Med Res Rev 1996;16:111-124.
44. Jain MK, Apitz-Castro R. Garlic: A product of spilled ambrosia. Curr Sci 1993;65:148-156.
45. Mohammad SM, Woodward SC. Characterization of a potent inhibitor of platelet aggregation and release reaction isolated from Allium sativum (garlic). Thromb Res 1986;44: 793-806.
46. Reuter HD, Sendl A. Allium sativum and Allium ursinum: Chemistry, pharmacology and medicinal applications. In: Wagner H, Farnsworth NR, eds. Economic and Medicinal Plants Research, Vol.6. London: Academic Press, 1994;55: 113.
47. Jain RC, Konar DB. Blood sugar lowering activity of garlic (Allium sativum Linn.). Medikon 1977;6:12-18.
48. Jain RC, Vyas CR, Mahatma OP. Hypoglycaemic action of onion and garlic. Lancet 1973;2:1491.
49. Jain RC, Vyas CR. Garlic in alloxan-induced diabetic rabbits. Am J Clin Nutr 1975;28:684-685.
50. Osman SA. Chemical and biological studies of onion and garlic in an attempt to isolate a hypoglycemic extract. In: Proceedings of the Fourth Asian Symposium of Medicinal Plants and Spices. Bangkok, 1980:117.
51. Zacharias NT, et al. Hypoglycemic and hypolipidemic effects of garlic in sucrose fed rats. Indian J Physiol Pharmacol 1980;24:151-154.
52. Srivastana VK, Afao Z. Garlic extract inhibits accumulation of polyols and hydration in diabetic rat lens. Curr Sci 1989;58:376-377.
53. Farva D, et al. Effects of garlic oil on streptozotocin-diabetic rats maintained on normal and high fat diets. Indian J Biochem Biophys 1986;23:24-27.
54. Venmadhi S, Devaki T. Studies on some liver enzymes in rats ingesting ethanol and treated with garlic oil. Medical Sci Res 1992;20:729-731.
55. Kumar CA, et al. Allium sativum: Effect of three weeks feeding in rats. Indian J Pharmacol 1981;13:91.
56. Chi MS, Koh ET, Stewart TJ. Effects of garlic on lipid metabolism in rats fed cholesterol or lard. J Nutr 1982;112:241-248.
57. Swanston-Flatt SK, et al. Traditional plant treatments for diabetes: Studies in normal and streptozotocin diabetic mice. Diabetologia 1990;33:462-464.
58. Mathew PT, Augusti KT. Studies on the effects of allicin (diallyl disulfide-oxide) on alloxan diabetes. Part I. Hypoglycemic action and enhancement of serum insulin effect and glycogen synthesis. Indian J Biochem Biophysics 1973; 10:209-221.
59. Rashid A, Hussain M, Khan HH. Bioassay for prostaglandinlike activity of garlic extract using isolated rat fundus strip and rat colon preparation. J Pakistan Med Assoc 1986; 36:138-141.
60. Neil HA, Silagy CA. Garlic: Its cardioprotectant properties. Curr Opin Lipidol 1994;5:6-10.
61. Silagy CA, Neil A. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994;12:463-468.
62. Chutani SK, Bordia A. The effect of fried versus raw garlic on fibrinolytic activity in man. Atherosclerosis 1981;38:417-421.
63. Bordia A. Garlic and coronary heart disease: Effects of a three-year treatment with garlic extract on the reinfarct and mortality rate [in German]. Deutsche Apotheker Zeitung 1989;129:16-17.
64. Kiesewetter H, et al. Effect of garlic on thrombocyte aggregation, microcirculation and other risk factors. Int J Clin Pharmacol Ther Toxicol 1991;29:151-155.
65. Sharma SB, Nasir A, Prabhu KM, et al. Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. J Ethnopharmacol 2003;85:201-206.
66. Sharma SB, Nasir A, Prabhu KM, Murthy PS. Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus. J Ethnopharmacol 2006;104: 367-373.
67. Ravi K, Rajasekaran S, Subramanian S. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocininduced diabetes in rats. Food Chem Toxicol 2005;43:1433-1439.
68. Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: A review. J Ethnopharmacol 2004;93:123-132.
69. Ahmad N, et al. Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Bangladesh Med Res Counc Bull 1999;25: 11-13.
70. Krawinkel M, et al. Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia. Nutr Rev 2006;64:331-337.
71. Chaturvedi P. Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet. Br J Biomed Sci 2005;62: 124-126.
72. Chen Q, et al. Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines. Br J Nutr 2005;93:747-754.
73. Sarkar A, Lavania SC, Pandey DN, Pant MC. Changes in the blood lipid profile after administration of Ocimum sanctum (tulsi) leaves in the normal albino rabbits. Indian J Physiol Pharmacol 1994;38:311-312.
74. Gupta S, Mediratta PK, Singh S, et al. Antidiabetic, antihypercholesterolaemic and antioxidant effect of Ocimum sanctum (Linn) seed oil. Indian J Exp Biol 2006;44:300-304.
75. Lele RD. Molecular Biology: A New Interface Between Ayurveda and Modern Medicine. Mumbai: Bhawan's Book University, Bhartiya Vidya Bhawan, 2001:477-478.
76. Srividya N, Periwal S. Diuretic, hypotensive and hypoglycaemic effect of Phyllanthus amarus. Indian J Exp Biol 1995; 33:861-864.
77. Khanna AK, Rizvi F, Chander R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J Ethnopharmacol 2002;82:19-22.
78. Rajak S, Banerjee SK, Sood S, et al. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytother Res 2004; 18:54-60.
79. Puri D, Prabhu KM, Murthy PS. Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Indian J Physiol Pharmacol 2002;46:457-462.
80. Narender T, Puri A, Shweta T, et al. 4-Hydroxyisoleucine: An unusual amino acid as antidyslipidemic and antihyperglycemic agent. Bioorg Med Chem Lett 2006;16:293-296.
81. Xue WL, Li XS, Zhang J, et al. Effect of Trigonella foenumgraecum (fenugreek) extracts on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 2007;16:422-426.
82. Raju J, Gupta D, Rao AR, et al. Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 2001;224:45-51.
83. Ali L, Azad Khan AK, Hassan Z, et al. Characterization of the hypoglycemic effects of Trigonella foenum graecum seed. Planta Med 1995;61:358-360.
84. Jung M, Park M, Lee HC, et al. Antidiabetic agents from medicinal plants. Curr Med Chem 2006;13:1203-1218.
85. Dwivedi S, Chansouria JPN, Somani PN, et al. Effect of Terminalia arjuna on ischemic heart disease. Altern Med 1989;3:115-122.
86. Dwivedi S,Kumar V. b-Thalassemia, hyperlipoproteinemia(a), andmetabolic syndrome: Its low-cost holistic therapy. J Altern Complement Med 2007;13:287-289.